Danaher Corporation  

(Public, NYSE:DHR)   Watch this stock  
Find more results for dhr
86.01
-0.29 (-0.34%)
Mar 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 85.61 - 86.88
52 week 75.71 - 102.79
Open 86.34
Vol / Avg. 3.11M/2.00M
Mkt cap 59.41B
P/E 27.98
Div/yield 0.14/0.65
EPS 3.07
Shares 693.28M
Beta 1.02
Inst. own 78%
Jan 24, 2017
Q4 2016 Danaher Corp Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 16.29% 12.76%
Operating margin 15.89% 15.24%
EBITD margin - 23.88%
Return on average assets 6.92% 4.61%
Return on average equity 12.97% 9.22%
Employees 62,000 -
CDP Score - 22

Address

2200 Pennsylvania Ave NW Ste 800w
WASHINGTON, DC 20037-1731
United States - Map
+1-202-8280850 (Phone)
+1-202-8280860 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Officers and directors

Steven M. Rales Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel L. Comas Chief Financial Officer, Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Rainer M. Blair Executive Vice President
Age: 52
Bio & Compensation  - Reuters
William K. Daniel II Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Robert S. Lutz Senior Vice President, Chief Accounting Officer
Age: 59
Bio & Compensation  - Reuters
Brian W. Ellis Senior Vice President, General Counsel
Age: 50
Bio & Compensation  - Reuters
Angela S. Lalor Senior Vice President - Human Resources
Age: 51
Bio & Compensation  - Reuters
William H. King Senior Vice President- Strategic Development
Age: 49
Bio & Compensation  - Reuters
Daniel A. Raskas Senior Vice President - Corporate Development
Age: 50
Bio & Compensation  - Reuters
Matthew E. Gugino Vice President, Investor Relations
Bio & Compensation  - Reuters